MBL International Acquires Antibody Business from LifeSpan BioSciences.Tokyo, Japan, Feb 14, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Medical and Biological Laboratories (MBL MBL Mobile MBL Marine Biological Laboratory MBL Macquarie Bank Limited MBL Mannose-Binding Lectin MBL Marine Boundary Layer MBL Member Business Lending (credit unions) MBL Movimiento Bolivia Libre ) announced on February 13 that its Massachusetts-based subsidiary MBL International has acquired the antibody business of LifeSpan BioSciences (LifeSpan) of Seattle. LifeSpan is a bio venture company that offers a wide range of antibodies, namely more than 900 types including 800 GPCR GPCR Guanine Nucleotide-Binding Protein-Coupled Receptor GPCR GTP-binding Protein-Coupled Receptor (G-protein coupled receptor receptor /re·cep·tor/ (-ter) 1. a molecule on the surface or within a cell that recognizes and binds with specific molecules, producing a specific effect in the cell; e.g. ) antibodies. With this move, MBL International now has more than 4,000 antibody products. Accordingly, it will promote its sales initiatives in the global market. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion